Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug

Epilepsy, Tonic-Clonic Clinical Trial

Official title:
A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Evaluation of Lamotrigine Adjunctive Therapy in Subjects Wtih Primary Generalized Tonic-Clonic Seizures

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the effectiveness and safety of an investigational new drug for supplemental therapy in subjects with primary generalized tonic-clonic (PGTC) seizures.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00043901
Study type	Interventional
Source	GlaxoSmithKline
Contact
Status	Completed
Phase	Phase 4
Start date	December 1, 2000
Completion date	March 1, 2005

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04770337` - Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy	N/A
Terminated	`NCT03831802` - Embrace and Quality of Life	N/A
Withdrawn	`NCT04282681` - XLTCS - Accelerometer Data Collection in an Epilepsy Monitoring Unit (EMU)
Completed	`NCT01439438` - Topiramate Bioequivalence Study Brazil - Fast	Phase 1
Completed	`NCT00150787` - Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.	Phase 3
Completed	`NCT00231556` - A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy	Phase 3
Completed	`NCT03446664` - Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study	N/A
Completed	`NCT00104416` - Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures	Phase 3
Completed	`NCT00150813` - Monotherapy With Levetiracetam in Patients Suffering From Epilepsy.	Phase 3